日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Remdesivir-bisPropionate, a better derivative of remdesivir against SARS-CoV-2: Comparison of in vitro and in vivo PK/PD Study as well as its therapeutic potential

瑞德西韦双丙酸酯,一种优于瑞德西韦的抗SARS-CoV-2衍生物:体外和体内药代动力学/药效学研究及其治疗潜力比较

Chakraborty, Ashok; Diwan, Anil; Chiniga, Vijetha; Arora, Vinod; Thakur, Yogesh; Tatake, Jayant; Pandey, Rajesh; Holkar, Preetam; Holkar, Neelam

Seasonal variation in immune thrombotic thrombocytopenic purpura in New England

新英格兰地区免疫性血栓性血小板减少性紫癜的季节性变化

Ruiz Lopez, Jorge N; Tatake, Ishan; Bendapudi, Pavan K

Cancer-Associated Thrombosis: Surveying Patients' Awareness and Education Needs

癌症相关血栓形成:患者认知和教育需求调查

Bueno, Andrew; Tatake, Ishan J; Li, Ang; Parks, Anna; Schaefer, Jordan K; Bernal, Alejandra Gutierrez; Chaturvedi, Shruti; Mahajan, Anjlee; May, Jori; Tefera, Leben; Lake, Leslie; Angelini, Dana; Patell, Rushad

Recombinant ADAMTS13 for Immune Thrombotic Thrombocytopenic Purpura

重组 ADAMTS13 治疗免疫性血栓性血小板减少性紫癜

Pavan K Bendapudi, Brody H Foy, Sarah B Mueller, Jun Liu, Louis M Feingold, Kristen E Burke, Wendy Cruz, Maria Y Chen, Emily S Lau, Rachel L Goldberg, Ishan Tatake, Shelby C Wilkinson, Brian J Carney, James R Stone, Doyun Park, Alzira R Avelino, Sajjad Hassan, Chester Andrzejewski, Kristen N Ruby, K

Prospect of nanomaterials as antimicrobial and antiviral regimen

纳米材料作为抗菌和抗病毒疗法的前景

Chakraborty, Ashok; Diwan, Anil; Tatake, Jayant

Mechanism of Antiviral Activities of Nanoviricide's Platform Technology based Biopolymer (NV-CoV-2)

基于纳米病毒杀灭剂平台技术的生物聚合物(NV-CoV-2)抗病毒活性机制

Chakraborty, Ashok; Diwan, Anil; Arora, Vinod; Thakur, Yogesh; Chiniga, Vijetha; Tatake, Jay; Pandey, Rajesh; Holkar, Preetam; Holkar, Neelam; Pond, Bethany

Dual effects of NV-CoV-2 biomimetic polymer: An antiviral regimen against COVID-19

NV-CoV-2仿生聚合物的双重效应:一种抗COVID-19病毒疗法

Chakraborty, Ashok; Diwan, Anil; Chiniga, Vijetha; Arora, Vinod; Holkar, Preetam; Thakur, Yogesh; Tatake, Jay; Barton, Randall; Holkar, Neelam; Pandey, Rajesh; Pond, Bethany

Development and Evaluation of an Optimal Human Single-Chain Variable Fragment-Derived BCMA-Targeted CAR T Cell Vector

最佳人类单链可变片段衍生的 BCMA 靶向 CAR T 细胞载体的开发和评估

Eric L Smith, Mette Staehr, Reed Masakayan, Ishan J Tatake, Terence J Purdon, Xiuyan Wang, Pei Wang, Hong Liu, Yiyang Xu, Sarah C Garrett-Thomson, Steven C Almo, Isabelle Riviere, Cheng Liu, Renier J Brentjens

MEK5 is activated by shear stress, activates ERK5 and induces KLF4 to modulate TNF responses in human dermal microvascular endothelial cells

MEK5 被剪切应力激活,激活 ERK5 并诱导 KLF4 调节人类真皮微血管内皮细胞中的 TNF 反应

Paul R Clark, Todd J Jensen, Martin S Kluger, Maurice Morelock, Adedayo Hanidu, Zhenhao Qi, Revati J Tatake, Jordan S Pober

Identification of pharmacological inhibitors of the MEK5/ERK5 pathway

鉴定 MEK5/ERK5 通路的药理抑制剂

Revati J Tatake, Margaret M O'Neill, Charles A Kennedy, Anita L Wayne, Scott Jakes, Di Wu, Stanley Z Kugler Jr, Mohammed A Kashem, Paul Kaplita, Roger J Snow